What is the treatment for a patient diagnosed with primary aldosteronism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Primary Aldosteronism

For unilateral primary aldosteronism, laparoscopic unilateral adrenalectomy is the definitive treatment, improving blood pressure in virtually 100% of patients and curing hypertension in approximately 38-50% of cases; for bilateral disease or patients unsuitable for surgery, lifelong treatment with spironolactone or eplerenone is the cornerstone of therapy. 1, 2

Determining Treatment Approach: Unilateral vs. Bilateral Disease

The critical first step after confirming primary aldosteronism is determining laterality, as this dictates whether the patient is a surgical candidate or requires lifelong medical therapy. 1

Imaging and Lateralization

  • Obtain a non-contrast CT scan of the adrenal glands as initial imaging to identify unilateral adenoma versus bilateral hyperplasia. 3
  • Adrenal venous sampling (AVS) is mandatory before offering adrenalectomy to distinguish unilateral from bilateral disease, except in patients <40 years when imaging shows a single affected gland (bilateral hyperplasia is rare in this population). 3
  • CT findings alone are insufficient for treatment decisions, as adenomas on imaging can represent hyperplasia and false positives are common due to nodular hyperplasia. 3

Surgical Treatment for Unilateral Disease

Laparoscopic unilateral adrenalectomy is the treatment of choice for unilateral aldosterone production. 1

Expected Surgical Outcomes

  • 95-99% of patients achieve biochemical cure (resolution of autonomous aldosterone secretion and hypokalemia). 2
  • Complete clinical success (cure of hypertension without medications) occurs in approximately 38-50% of patients. 1, 2
  • Blood pressure improves in virtually 100% of patients, even those not achieving complete cure. 1
  • Surgical patients require significantly shorter follow-up (mean 6.5 months vs 13.4 months for medical therapy) and can be discharged to community care more quickly. 2

Additional Benefits of Surgery

  • Resolves hypokalemia completely. 1
  • Lowers blood pressure and reduces the number of antihypertensive medications required. 1
  • Improves parameters of impaired cardiac and kidney function. 1
  • Reverses left ventricular hypertrophy. 1

Medical Treatment for Bilateral Disease or Non-Surgical Candidates

For patients with bilateral aldosterone hypersecretion or those unsuitable for surgery, spironolactone or eplerenone is the agent of choice. 1, 4

Spironolactone Dosing

  • For primary hyperaldosteronism, administer spironolactone 100-400 mg daily in preparation for surgery or as long-term maintenance therapy at the lowest effective dosage. 4
  • Start with 100 mg daily and titrate to maintain a high-normal serum potassium concentration without oral potassium supplements. 3, 5
  • Doses can be administered in single or divided doses. 4

Eplerenone as Alternative

  • Eplerenone is an alternative option with fewer anti-androgenic side effects compared to spironolactone (avoiding gynecomastia). 3, 2
  • Eplerenone is less potent than spironolactone and requires twice-daily administration. 3

Adjunctive Medical Therapy

  • Combine mineralocorticoid receptor antagonists with a low-sodium diet for optimal blood pressure control. 5
  • Additional conventional antihypertensive medications may be required as needed. 6
  • Long-acting calcium channel blockers and alpha-receptor antagonists minimally interfere with aldosterone-renin ratio and can be used as adjuncts. 3

Monitoring and Follow-Up

For Medical Therapy

  • Monitor serum potassium within 1 week of spironolactone initiation and regularly thereafter. 3
  • Risk of hyperkalemia is increased in older patients, those with diabetes, chronic kidney disease, or concomitant use of ACE inhibitors/ARBs/NSAIDs. 3
  • Lifelong medication adherence and monitoring for side effects (gynecomastia with spironolactone, hyperkalemia risk) is required. 2

Post-Surgical Monitoring

  • Even after successful adrenalectomy, some patients have residual hypertension due to vascular remodeling from delayed diagnosis. 3
  • The rate of cure is higher when diagnosis is made early in the disease course. 3
  • Ensure adequate blood pressure control and assess for need of continued antihypertensive medications. 3

Special Considerations

Familial Hyperaldosteronism Type 1

  • This rare form can be corrected with low-dose dexamethasone, which is free of glucocorticoid effects and safe during pregnancy. 3

Common Pitfalls to Avoid

  • Never proceed to surgery based on CT findings alone without adrenal venous sampling (except in patients <40 years with unilateral imaging findings). 3
  • Up to 25% of patients might undergo unnecessary adrenalectomy based on CT findings alone. 3
  • Do not rely on presence or absence of hypokalemia to guide treatment decisions, as it is absent in approximately 50% of cases. 3

Referral Recommendations

  • All patients with confirmed primary aldosteronism should be referred to a hypertension specialist or endocrinologist for subtype determination and treatment planning. 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluating Curative Outcomes After Surgery for Primary Aldosteronism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Screening for Primary Aldosteronism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Primary aldosteronism: Treatment of the disease, and new therapeutic approaches.

Best practice & research. Clinical endocrinology & metabolism, 2020

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.